Back

Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome-dependent pyroptosis

( - )
Organised by:
Congress Presentation Part of: Abstract Programme Inflammation ESC Premium Access ESC Asia with APSC & AFC 2020

About the speaker

Photo
Doctor Ao Chen

Zhongshan Hospital Fudan University, Shanghai (China)

238 More presentations in this session

Presentation thumbnail
2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.
Doctor D. Pol (Melbourne, AU)
Abstract
Presentation thumbnail
3D right ventricular ejection fraction and longitudinal strain are independent predictors of major adverse cardiovascular events in patients with rrhythmogenic right ventricular cardiomyopathy
Assistant Professor L. Hosseini (Bojnurd, IR)
Abstract
Presentation thumbnail
A novel pressure-regulated deployment strategy for improving the safety and efficacy of balloon-expandable transcatheter aortic valves
Doctor A. Snir (Oxford, GB)
Abstract Video
Presentation thumbnail
A novel therapeutic approach for coronary inflammation and lymphatic vessels using non-invasive low-intensity pulsed ultrasound in a porcine model with DES-induced coronary hyperconstricting responses
Doctor T. Watanabe (Sendai, JP)
Abstract Video
Presentation thumbnail
A real-world comparison of outcomes between fractional flow reserve-guided versus angiography-guided percutaneous coronary intervention
Doctor C. Wong (Sydney, AU)
Abstract

Access the full session

Session thumbnail
Abstract Programme

The Event

Event poster

ESC Asia with APSC & AFC 2020

You may be interested in
thumbnail
Congress Presentation
Interference with NLRP3-inflammasome mediated signaling does not reduce myocardial ischemia reperfusion injury in a pig model of myocardial infarction
30 June 2021
thumbnail
Congress Presentation
The effect of atorvastatin on mevalonate levels in blood plasma in patients with coronary heart disease and muscle side effects
25 April 2024
thumbnail
Congress Presentation
PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study
1 September 2025
thumbnail
Congress Presentation
Pyroptosis is not likely to play a major role in anthracycline-induced cytotoxicity in H9c2 cardiomyocytes and human cardiac endothelial cells
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources